These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33451326)

  • 21. Antivirals against enteroviruses: a critical review from a public-health perspective.
    Benschop KS; van der Avoort HG; Duizer E; Koopmans MP
    Antivir Ther; 2015; 20(2):121-30. PubMed ID: 25643052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2C protein of Enterovirus: key protein of viral replication and antiviral target.
    El Kazzi P; Yaacoub C; Fajloun Z; Vanelle P; Decoly E; Coutard B; Barral K
    Virologie (Montrouge); 2023 Jun; 27(3):35-49. PubMed ID: 37476987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Essential Role of Enterovirus 2A Protease in Counteracting Stress Granule Formation and the Induction of Type I Interferon.
    Visser LJ; Langereis MA; Rabouw HH; Wahedi M; Muntjewerff EM; de Groot RJ; van Kuppeveld FJM
    J Virol; 2019 May; 93(10):. PubMed ID: 30867299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68.
    Ma C; Hu Y; Zhang J; Musharrafieh R; Wang J
    ACS Infect Dis; 2019 Nov; 5(11):1952-1962. PubMed ID: 31532189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of dibucaine derivatives as novel potent enterovirus 2C helicase inhibitors: In vitro, in vivo, and combination therapy study.
    Tang Q; Xu Z; Jin M; Shu T; Chen Y; Feng L; Zhang Q; Lan K; Wu S; Zhou HB
    Eur J Med Chem; 2020 Sep; 202():112310. PubMed ID: 32619885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic targets for enterovirus infections.
    Laajala M; Reshamwala D; Marjomäki V
    Expert Opin Ther Targets; 2020 Aug; 24(8):745-757. PubMed ID: 32552314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C.
    Bauer L; Manganaro R; Zonsics B; Hurdiss DL; Zwaagstra M; Donselaar T; Welter NGE; van Kleef RGDM; Lopez ML; Bevilacqua F; Raman T; Ferla S; Bassetto M; Neyts J; Strating JRPM; Westerink RHS; Brancale A; van Kuppeveld FJM
    PLoS Biol; 2020 Nov; 18(11):e3000904. PubMed ID: 33156822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.
    Egorova A; Ekins S; Schmidtke M; Makarov V
    Eur J Med Chem; 2019 Sep; 178():606-622. PubMed ID: 31226653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of enterovirus 71 infection by antisense octaguanidinium dendrimer-conjugated morpholino oligomers.
    Tan CW; Chan YF; Quah YW; Poh CL
    Antiviral Res; 2014 Jul; 107():35-41. PubMed ID: 24769243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emetine protects mice from enterovirus infection by inhibiting viral translation.
    Tang Q; Li S; Du L; Chen S; Gao J; Cai Y; Xu Z; Zhao Z; Lan K; Wu S
    Antiviral Res; 2020 Jan; 173():104650. PubMed ID: 31734270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent developments in antiviral agents against enterovirus 71 infection.
    Tan CW; Lai JK; Sam IC; Chan YF
    J Biomed Sci; 2014 Feb; 21(1):14. PubMed ID: 24521134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent inhibition of enterovirus D68 and human rhinoviruses by dipeptidyl aldehydes and α-ketoamides.
    Kim Y; Kankanamalage AC; Damalanka VC; Weerawarna PM; Groutas WC; Chang KO
    Antiviral Res; 2016 Jan; 125():84-91. PubMed ID: 26658373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innate Immunity Evasion by Enteroviruses: Insights into Virus-Host Interaction.
    Lei X; Xiao X; Wang J
    Viruses; 2016 Jan; 8(1):. PubMed ID: 26784219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and evaluation of 2'-acetylene-7-deaza-adenosine phosphoamidate derivatives as anti-EV71 and anti-EV-D68 agents.
    Yan L; Cao R; Zhang H; Li Y; Li W; Li X; Fan S; Li S; Zhong W
    Eur J Med Chem; 2021 Dec; 226():113852. PubMed ID: 34560428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral Combination Approach as a Perspective to Combat Enterovirus Infections.
    Galabov AS; Nikolova I; Vassileva-Pencheva R; Stoyanova A
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(2):91-9. PubMed ID: 27442375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of human enterovirus 71 infection by kappa carrageenan.
    Chiu YH; Chan YL; Tsai LW; Li TL; Wu CJ
    Antiviral Res; 2012 Aug; 95(2):128-34. PubMed ID: 22643729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of broad-spectrum enterovirus antivirals based on quinoline scaffold.
    Musharrafieh R; Kitamura N; Hu Y; Wang J
    Bioorg Chem; 2020 Aug; 101():103981. PubMed ID: 32559580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Replication and Inhibitors of Enteroviruses and Parechoviruses.
    van der Linden L; Wolthers KC; van Kuppeveld FJ
    Viruses; 2015 Aug; 7(8):4529-62. PubMed ID: 26266417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new paradigm in viral resistance.
    Ruiz A; Russell SJ
    Cell Res; 2012 Nov; 22(11):1515-7. PubMed ID: 23033124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71.
    Ho JY; Chern JH; Hsieh CF; Liu ST; Liu CJ; Wang YS; Kuo TW; Hsu SJ; Yeh TK; Shih SR; Hsieh PW; Chiu CH; Horng JT
    J Antimicrob Chemother; 2016 Jul; 71(7):1922-32. PubMed ID: 27098012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.